TD Securities Upgrades Aurora Cannabis (NASDAQ:ACB) to “Strong-Buy”

Aurora Cannabis (NASDAQ:ACB) was upgraded by equities research analysts at TD Securities to a “strong-buy” rating in a research note issued on Thursday,Zacks.com reports.

Separately, TD Cowen began coverage on Aurora Cannabis in a research note on Wednesday. They issued a “buy” rating on the stock.

Aurora Cannabis Price Performance

Shares of ACB stock opened at $4.31 on Thursday. The stock has a market cap of $236.36 million, a price-to-earnings ratio of -5.67 and a beta of 1.86. The business’s fifty day moving average is $5.00 and its 200 day moving average is $5.54. Aurora Cannabis has a twelve month low of $2.84 and a twelve month high of $9.35. The company has a quick ratio of 1.88, a current ratio of 3.83 and a debt-to-equity ratio of 0.07.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of ACB. Cetera Advisors LLC bought a new position in shares of Aurora Cannabis during the first quarter valued at $59,000. TD Asset Management Inc bought a new position in Aurora Cannabis in the second quarter valued at about $255,000. Headlands Technologies LLC lifted its holdings in Aurora Cannabis by 98.8% in the second quarter. Headlands Technologies LLC now owns 74,988 shares of the company’s stock valued at $346,000 after acquiring an additional 37,269 shares during the period. Cubist Systematic Strategies LLC bought a new position in Aurora Cannabis in the second quarter valued at about $50,000. Finally, Toronto Dominion Bank increased its position in Aurora Cannabis by 34,356.4% in the second quarter. Toronto Dominion Bank now owns 18,951 shares of the company’s stock worth $88,000 after buying an additional 18,896 shares in the last quarter. 47.63% of the stock is owned by institutional investors.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.